Form 4: Harte Hanks Director Radoff Receives RSU Grant

Harte Hanks Director Bradley Louis Radoff was granted 27,861 Restricted Stock Units at $3.23 per share, vesting in one year.

Summary

• Bradley Louis Radoff, a Director at Harte Hanks Inc. (HHS), reported an acquisition of equity securities.
• Radoff was granted 27,861 Restricted Stock Units (RSU shares) on December 9, 2025.
• The RSU shares were granted at a price of $3.23 per share.
• These RSU shares will vest 100% on the first anniversary of the grant date, specifically on December 9, 2026.
• Following this transaction, Radoff beneficially owns 27,861 RSU shares (indirectly), 391,399 shares of Common Stock (directly), 20,000 shares of Common Stock (indirectly held in an IRA), and 12,048 shares of Common Stock (directly, which vested on May 23, 2025).

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a director is generally a positive signal, indicating alignment of interests and a commitment to the company's future. It's not a direct cash investment but ties the director's compensation to stock performance.

Positives

• The grant of 27,861 Restricted Stock Units to a Director aligns management's interests with those of shareholders.
• The one-year vesting schedule for the RSU shares encourages long-term commitment and performance from the director.

Future Outlook

The RSU grant with a one-year vesting period indicates an expectation of continued service and performance from the director, aligning their future incentives with the company's long-term success.

Industry Context

This RSU grant is a standard form of equity compensation for directors in publicly traded companies, aiming to align their interests with long-term shareholder value creation. It reflects common corporate governance practices for executive and director incentives.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of director's interests with long-term stock performance.
• Employees: No direct impact mentioned.
• Customers/Suppliers/Creditors: No direct impact mentioned.

Next Steps

• The 27,861 RSU shares granted on December 9, 2025, are scheduled to vest on December 9, 2026.

Key Dates

Recommendation

While the RSU grant to a director is a positive signal of alignment and confidence, a Form 4 filing alone, which details an equity compensation event rather than a significant open market purchase or sale, typically does not warrant a change in investment recommendation. It reinforces a 'hold' stance for investors already in the stock, as it suggests continued stability in governance and incentives.

Keywords

Harte Hanks, HHS, Bradley Radoff, Form 4, Insider Transaction, Restricted Stock Units, RSU Grant, Director Compensation, Equity Compensation